3M Settles PFAS-Related Claims with New Jersey for $285 Million, Resolving Legacy Chambers Works Litigation

Reuters
昨天
<a href="https://laohu8.com/S/MMM">3M</a> Settles PFAS-Related Claims with New Jersey for $285 Million, Resolving Legacy Chambers Works Litigation

3M Company has reached a significant agreement to settle all legacy claims related to the Chambers Works site in Salem County, New Jersey. The site, formerly owned by DuPont and now by The Chemours Company, has been at the center of litigation concerning PFAS contamination. The settlement, which is subject to court approval, involves a financial commitment from 3M, including a pre-tax present value of approximately $210 million to address the Chambers Works litigation and other settlement elements. Additionally, 3M has agreed to a pre-tax present value commitment of roughly $75 million to resolve current and future PFAS-related claims by the State of New Jersey, with payments commencing in 2030 and continuing through 2050. This resolution marks a crucial step for 3M in managing risk and uncertainty related to its historical operations and aligns with its strategic priorities.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 3M Company published the original content used to generate this news brief via PR Newswire (Ref. ID: CG85963) on May 12, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10